Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211763200 on June 2, 2003

J. Biol. Chem., Vol. 278, Issue 32, 29799-29812, August 8, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/32/29799    most recent
M211763200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beck, S.
Right arrow Articles by Kaszkin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beck, S.
Right arrow Articles by Kaszkin, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Potentiation of Tumor Necrosis Factor {alpha}-induced Secreted Phospholipase A2 (sPLA2)-IIA Expression in Mesangial Cells by an Autocrine Loop Involving sPLA2 and Peroxisome Proliferator-activated Receptor {alpha} Activation*

Sabine Beck {ddagger}, Gérard Lambeau §, Kristen Scholz-Pedretti {ddagger}, Michael H. Gelb ¶, Marcel J. W. Janssen ||, Suzanne H. Edwards **, David C. Wilton **, Josef Pfeilschifter {ddagger} and Marietta Kaszkin {ddagger} {ddagger}{ddagger}

From the {ddagger}Center of Pharmacology, University Hospital Frankfurt, 60590 Frankfurt, Germany, the §Institut de Pharmacologie Moléculaire et Cellulaire, CNRS-UPR 411, 660 Route de Lucioles, Sophia Antipolis, 06560 Valbonne, France, the Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, the ||Department of Clinical Chemistry, Academic Medical Center, 1100 DD Amsterdam, The Netherlands, and the **Division of Biochemistry and Molecular Biology, School of Biological Sciences, University of Southampton, Southampton SO16 7PX, United Kingdom

In rat mesangial cells, exogenously added secreted phospholipases A2 (sPLA2s) potentiate the expression of pro-inflammatory sPLA2-IIA first induced by cytokines like tumor necrosis factor-{alpha} (TNF{alpha}) and interleukin-1{beta}. The transcriptional pathway mediating this effect is, however, unknown. Because products of PLA2 activity are endogenous activators of peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}, we postulated that sPLA2s mediate their effects on sPLA2-IIA expression via sPLA2 activity and subsequent PPAR{alpha} activation. This study shows that various sPLA2s, including venom enzymes, human sPLA2-IIA, and wild-type and catalytically inactive H48Q mutant of porcine pancreatic sPLA2-IB, enhance the TNF{alpha}-induced sPLA2-IIA expression at the mRNA and protein levels. In cells transfected with luciferase sPLA2-IIA promoter constructs, sPLA2s are active only when the promoter contains a functional PPRE-1 site. The effect of exogenous sPLA2s is also blocked by the PPAR{alpha} inhibitor MK886. Interestingly, the expression of sPLA2-IIA induced by TNF{alpha} alone is also attenuated by MK886, by the sPLA2-IIA inhibitor LY311727, by heparinase, which prevents the binding of sPLA2-IIA to heparan sulfate proteoglycans, and by the specific cPLA2-{alpha} inhibitor pyrrolidine-1. Together, these data indicate that sPLA2-IIA released from mesangial cells by TNF{alpha} stimulates its own expression via an autocrine loop involving cPLA2 and PPAR{alpha}. This signaling pathway is also used by exogenously added sPLA2s including pancreatic sPLA2-IB and is distinct from that used by TNF{alpha}.


Received for publication, November 19, 2002 , and in revised form, May 23, 2003.

* This work was supported by a grant from the Wilhelm Sander Stiftung (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Pharmazentrum Frankfurt, Klinikum der J. W. Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. Tel.: 49-69-6301-83105; Fax: 49-69-6301-83202; E-mail: kaszkin{at}em.uni-frankfurt.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Yan, G. Dalmasso, H. T. T. Nguyen, T. S. Obertone, L. Charrier-Hisamuddin, S. V. Sitaraman, and D. Merlin
Nuclear Factor-{kappa}B Is a Critical Mediator of Ste20-Like Proline-/Alanine-Rich Kinase Regulation in Intestinal Inflammation
Am. J. Pathol., October 1, 2008; 173(4): 1013 - 1028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. N. Birts, C. H. Barton, and D. C. Wilton
A Catalytically Independent Physiological Function for Human Acute Phase Protein Group IIA Phospholipase A2: CELLULAR UPTAKE FACILITATES CELL DEBRIS REMOVAL
J. Biol. Chem., February 22, 2008; 283(8): 5034 - 5045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kuwata, C. Fujimoto, E. Yoda, S. Shimbara, Y. Nakatani, S. Hara, M. Murakami, and I. Kudo
A Novel Role of Group VIB Calcium-independent Phospholipase A2 (iPLA2{gamma}) in the Inducible Expression of Group IIA Secretory PLA2 in Rat Fibroblastic Cells
J. Biol. Chem., July 13, 2007; 282(28): 20124 - 20132.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Brant, W. Guan, P. Tithof, and R. L. Caruso
Gestation Age-Related Increase in 50-kDa Rat Uterine Calcium-Independent Phospholipase A2 Expression Influences Uterine Sensitivity to Polychlorinated Biphenyl Stimulation
Biol Reprod, May 1, 2006; 74(5): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Varastehpour, T. Radaelli, J. Minium, H. Ortega, E. Herrera, P. Catalano, and S. Hauguel-de Mouzon
Activation of Phospholipase A2 Is Associated with Generation of Placental Lipid Signals and Fetal Obesity
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 248 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Petry, A. Huwiler, W. Eberhardt, M. Kaszkin, and J. Pfeilschifter
Hypoxia Increases Group IIA Phospholipase A2 Expression under Inflammatory Conditions in Rat Renal Mesangial Cells
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2897 - 2905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo
Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway
J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jaulmes, B. Janvier, M. Andreani, and M. Raymondjean
Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1161 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. N.M. Ilsley, M. Nakanishi, C. Flynn, G. S. Belinsky, S. De Guise, J. N. Adib, R. T. Dobrowsky, J. V. Bonventre, and D. W. Rosenberg
Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis
Cancer Res., April 1, 2005; 65(7): 2636 - 2643.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Bleker, F. Sonntag, and J. A. Kleinschmidt
Mutational Analysis of Narrow Pores at the Fivefold Symmetry Axes of Adeno-Associated Virus Type 2 Capsids Reveals a Dual Role in Genome Packaging and Activation of Phospholipase A2 Activity
J. Virol., February 15, 2005; 79(4): 2528 - 2540.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Granata, A. Petraroli, E. Boilard, S. Bezzine, J. Bollinger, L. Del Vecchio, M. H. Gelb, G. Lambeau, G. Marone, and M. Triggiani
Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor
J. Immunol., January 1, 2005; 174(1): 464 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pawliczak, C. Logun, P. Madara, M. Lawrence, G. Woszczek, A. Ptasinska, M. L. Kowalski, T. Wu, and J. H. Shelhamer
Cytosolic Phospholipase A2 Group IV{alpha} but Not Secreted Phospholipase A2 Group IIA, V, or X Induces Interleukin-8 and Cyclooxygenase-2 Gene and Protein Expression through Peroxisome Proliferator-activated Receptors {gamma} 1 and 2 in Human Lung Cells
J. Biol. Chem., November 19, 2004; 279(47): 48550 - 48561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-A. Choi, H.-K. Lim, J.-R. Kim, C.-H. Lee, Y.-J. Kim, S.-S. Kang, and S.-H. Baek
Group IB Secretory Phospholipase A2 Promotes Matrix Metalloproteinase-2-mediated Cell Migration via the Phosphatidylinositol 3-Kinase and Akt Pathway
J. Biol. Chem., August 27, 2004; 279(35): 36579 - 36585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement